Principaux concurrents
Rendement du dividende (N) Rendement du dividende (N+1) PER (N) Price to Book (N) VE / CA (N) VE / EBITDA (N) VE / EBIT (N) Capi.($)
- - - - - - - 0
0,62%0,7%16.39x1.91x3.56x9.6x10.51x 64,28 Md
0,57%0,58%27.8x4.19x5.64x16.51x20.56x 57,29 Md
-.--%-.--%33.34x6.69x11.27x21.36x25.08x 43,45 Md
3,59%3,7%-51.07x2.33x3.04x8.99x10.49x 38,02 Md
-.--%-.--%34.88x1.72x3.71x11.39x13.25x 31,98 Md
-.--%-.--%-7.78x4.58x11.08x-6.75x-6.41x 27,66 Md
-.--%-.--%16.77x3.35x3.14x9.51x9.42x 22,91 Md
-.--%0,06%47.36x4.79x5.16x35.75x33.03x 17,74 Md
-.--%-.--%25.75x3.64x5.35x14.4x19.9x 16,45 Md
-.--%-.--%-32.29x-5.6x15.04x-45.74x-47.54x 14,1 Md
-.--%-.--%-122.61x12800.32x12.51x-110.82x-121.76x 12,41 Md
0,15%0,16%62.85x25.63x38.19x54.01x55.7x 12,95 Md
-.--%-.--%16.75x - 3.57x13.08x15.68x 11,15 Md
-.--%-.--%48.28x - - - - 11,15 Md
2,8%3,23%12x1.05x1.82x7.34x9.84x 6,27 Md
1,78%1,97%12.6x1.16x2.1x5.51x6.58x 5,51 Md
-.--%-.--%-99.81x - - - - 5,07 Md
Moyenne 0,56% 0,61% 2,42x 918,27x 8,35x 2,94x 3,62x 22,13 Md
Moyenne pondérée par Capi. 0,6% 0,64% 9,79x 431,89x 7,22x 7,85x 9,24x
Biopharmacies